Omar S Aljitawi

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. pmc Bendamustine associated with irreversible ascending paralysis
    Ashraf Alhafez
    Internal Medicine Department, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Case Rep Hematol 2013:931519. 2013
  2. pmc Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation
    Omar S Aljitawi
    Division of Hematology Oncology and Blood and Marrow Transplantation Program, 2330 Shawnee Mission Parkway, University of Kansas Medical Center, Kansas City, KS 66205, USA Electronic address
    Blood Cells Mol Dis 52:59-67. 2014
  3. doi request reprint Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells
    Omar S Aljitawi
    Blood and Marrow Transplant Program, University of Kansas Medical Center, Kansas City, Kansas, USA
    Stem Cells Dev 22:18-26. 2013
  4. doi request reprint Ex vivo expansion of umbilical cord blood: where are we?
    Omar S Aljitawi
    The Blood and Marrow Transplant Program, University of Kansas Medical Center, Kansas City, KS, USA
    Int J Hematol 95:371-9. 2012
  5. ncbi request reprint Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation
    Kyle R Brownback
    Division of Pulmonary and Critical Care Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    Ann Hematol 93:847-54. 2014
  6. doi request reprint Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
    Siddhartha Ganguly
    Blood and Marrow Transplantation Program, University of Kansas Medical Center, Kansas City, KS 66205, USA
    Clin Transplant 26:447-53. 2012
  7. ncbi request reprint Multiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what's new?
    Omar S Aljitawi
    The Blood and Marrow Transplant Program, University of Kansas Medical Center, Kansas City, KS, USA 2330 Shawnee Mission Pkwy, Westwood, KS 66205, USA
    J Comp Eff Res 1:57-70. 2012
  8. pmc Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
    Claudio G Brunstein
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA
    Blood 118:282-8. 2011

Detail Information

Publications8

  1. pmc Bendamustine associated with irreversible ascending paralysis
    Ashraf Alhafez
    Internal Medicine Department, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Case Rep Hematol 2013:931519. 2013
    ..Many adverse effects, including a rare case of reversible neurotoxicity, have been reported in association with bendamustine. Herein, we report the first case of irreversible ascending paralysis related to bendamustine...
  2. pmc Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation
    Omar S Aljitawi
    Division of Hematology Oncology and Blood and Marrow Transplantation Program, 2330 Shawnee Mission Parkway, University of Kansas Medical Center, Kansas City, KS 66205, USA Electronic address
    Blood Cells Mol Dis 52:59-67. 2014
    ..In vivo imaging demonstrated that HBO mice had significantly higher ventral and dorsal bioluminescence values. These studies suggest that HBO treatment of NSG mice prior to UCB CD34⁺ cell infusion significantly improves engraftment...
  3. doi request reprint Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells
    Omar S Aljitawi
    Blood and Marrow Transplant Program, University of Kansas Medical Center, Kansas City, Kansas, USA
    Stem Cells Dev 22:18-26. 2013
    ..In the other method, WJMSCs were cultured to form spheroids. Our findings demonstrate that WJMSCs may have the capacity for ectodermal differentiation...
  4. doi request reprint Ex vivo expansion of umbilical cord blood: where are we?
    Omar S Aljitawi
    The Blood and Marrow Transplant Program, University of Kansas Medical Center, Kansas City, KS, USA
    Int J Hematol 95:371-9. 2012
    ..In this review, we focus on the issue of limited cell dose in UCB units and discuss the possible approaches to overcome this limitation. We also summarize the various cellular pathways that have been explored to expand UCB units...
  5. ncbi request reprint Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation
    Kyle R Brownback
    Division of Pulmonary and Critical Care Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    Ann Hematol 93:847-54. 2014
    ..PES is a common complication following cord blood transplantation, with hypoxemia being present in over half of patients with PES. Hypoxemia with PES and treatment with corticosteroids may portend a worse prognosis. ..
  6. doi request reprint Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
    Siddhartha Ganguly
    Blood and Marrow Transplantation Program, University of Kansas Medical Center, Kansas City, KS 66205, USA
    Clin Transplant 26:447-53. 2012
    ..In conclusion, in this prospective pilot study, prophylactic use of zoledronic acid to prevent early bone loss was found to be safe and feasible in patients with AML undergoing allo-SCT during the immediate post-transplantation period...
  7. ncbi request reprint Multiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what's new?
    Omar S Aljitawi
    The Blood and Marrow Transplant Program, University of Kansas Medical Center, Kansas City, KS, USA 2330 Shawnee Mission Pkwy, Westwood, KS 66205, USA
    J Comp Eff Res 1:57-70. 2012
    ..In this article, we review the published literature regarding preparative regimens used in patients with multiple myeloma undergoing autologous stem cell transplantation. ..
  8. pmc Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
    Claudio G Brunstein
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA
    Blood 118:282-8. 2011
    ..The trials are registered at www.clinicaltrials.gov under NCT00864227 (BMT CTN 0604) and NCT00849147 (BMT CTN 0603)...